Pronostics in Austria and Germany agreement with Medipan
This article was originally published in Clinica
Multiplexed diagnostics manufacturer Pronostics has signed up German medical device distributor Medipan, as the exclusive marketer of its UltraPlex assays in Germany and Austria. The deal will see Berlin-based Medipan distribute Pronostics' UltraPlex ANA, Coeliac and Thyroid autoimmune disease biomarker assays to hospitals and private laboratories throughout the two countries. According to Cambridge, UK-based Pronostics, the deal could initially generate around E2m ($3.2m) in revenue annually, however, no other financial details were disclosed. Pronostics claims that in 2005, the worldwide market for autoimmune tests was in the region of $250m and is expected to grow to around $410m by 2010. The UltraPlex ANA, the firm's lead technology, enables 11 tests to be carried out at once using a microscopic bar-coding system. This helps reduce time and costs, when compared to existing serial testing methods, such as Hep-2 screens and ELISA tests.